This inventor holds 1 USPTO granted patent. Top assignees: Centre Hospitalier Universitaire De Nice, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Duc Duy Vo: Innovator in Oncology
Introduction
Duc Duy Vo is a notable inventor based in Umea, Sweden. He has made significant contributions to the field of medicine, particularly in oncology. His work focuses on developing new compounds that can aid in the treatment of various cancers.
Latest Patents
Duc Duy Vo holds 1 patent for his invention titled "Neomycin based compounds, and pharmaceutical use thereof." This patent relates to the development of new compounds that are useful in treating cancers such as glioblastoma, colorectal, and breast cancers. The invention also encompasses pharmaceutical compositions that include these compounds, showcasing his innovative approach to cancer treatment.
Career Highlights
Throughout his career, Duc Duy Vo has worked with prestigious institutions, including Université Côte d'Azur and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to collaborate with leading experts in the field of oncology.
Collaborations
Duc Duy Vo has collaborated with notable colleagues such as Thierry Virolle and Maria Duca. These partnerships have contributed to the advancement of his research and the development of his patented compounds.
Conclusion
Duc Duy Vo's innovative work in oncology demonstrates his commitment to improving cancer treatment through the development of new pharmaceutical compounds. His contributions are significant in the ongoing fight against cancer, and his patents reflect his dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile